Author:
Liang Jun,Fang Qichuan,Jiao Xiaoyi,Xiang Peng,Ma Junhao,Zhang Zijiao,Liu Yongcheng,He Yunfan,Li Yingjun,He Zhixu,Lei Jianbo
Funder
Zhejiang Provincial Natural Science Foundation of China
Key Research and Development Program of Zhejiang Province
Municipal Natural Science Foundation of Beijing
National TCM innovation team and talent support projects
Hainan Province Science and Technology special fund
Hainan Province Clinical Medical Center
Publisher
Springer Science and Business Media LLC
Reference77 articles.
1. Watson, A., Chapman, R., Shafai, G. & Maricich, Y. A. FDA regulations and prescription digital therapeutics: evolving with the technologies they regulate. Front Digit Health 5, 1086219 (2023).
2. R Niakan Kalhori, S. et al. Digital health solutions to control the COVID-19 pandemic in countries with high disease prevalence: literature review. J. Med Internet Res. 23, e19473 (2021).
3. Chen, X. & Luo, Y. Digital therapeutics in migraine management: a novel treatment option in the COVID-19 Era. J. Pain. Res. 16, 111–117 (2023).
4. Wang, C., Lee, C. & Shin, H. Digital therapeutics from bench to bedside. NPJ Digit. Med. 6, 38 (2023).
5. Digital Therapeutics Alliance. DTA’s Adoption & Interpretation of ISO’s DTx Definition, https://dtxalliance.org/wp-content/uploads/2023/06/DTA_FS_New-DTx-Definition.pdf (2023).